Advertisement

SPRING-2 — The First Phase III Trial of Dolutegravir in ART-Naive Patients

Summary and Comment |
February 11, 2013

SPRING-2 — The First Phase III Trial of Dolutegravir in ART-Naive Patients

Advertisement